Such studies have the potential to lead to the development of a novel, molecular-targeted therapy for HCC.23 In the present study, PTP4A3/PRL-3 was obtained in poorly differentiated HCC tissues by examining the genome-wide expression profile of HCC generated by cDNA microarray. This evidence concerns the gene PTP4A3 and hepatocellular carcinoma.